Tianjin Zhong Xin Pharmaceutical Group Corporation Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianjin Zhong Xin Pharmaceutical Group Corporation Limited with three other
companies in this sector in China:
Zhejiang Conba Pharmaceutical Co., Ltd.
sales of 6.02 billion Chinese Renmimbi [US$874.26 million]
of which 65%
Dong-E-E-Jiao Co Ltd
(6.32 billion Chinese Renmimbi [US$917.50 million]
of which 89%
was Medicine Manufacturing), and
Zhejiang Medicine Co., Ltd.
(5.28 billion Chinese Renmimbi [US$766.69 million]
of which 44%
was Life Nourishment).
During the year ended December of 2016, sales at
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited were 6.18 billion Chinese Renmimbi (US$897.41 million).
decrease of 12.7%
versus 2015, when the company's sales were 7.08 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 24.1% decline
in Western Medicine, from 2.16 billion Chinese Renmimbi to 1.64 billion Chinese Renmimbi.
There were also decreases in sales in
Chinese Medicine (down 6.8% to 4.07 billion Chinese Renmimbi)
Others (down 15.2% to 471.65 million Chinese Renmimbi)